Letters to the Editor Open access

Proton pump inhibitor prescribing at hospital discharge: a real-world analysis from two Italian internal medicine units

Authors

Published
23 September 2026
Section
Letters to the Editor
DOI
10.4081/itjm.2026.2656

Abstract

Dear Editor,
Proton pump inhibitors are highly effective for acid-related disorders and for gastrointestinal protection in selected high-risk patients...

Keywords

References

  1. Scarpignato C, Gatta L, Zullo A, et al. Effective and safe proton pump inhibitor therapy in acid-related diseases: a position paper addressing benefits and potential harms of acid suppression. BMC Med 2016;14:179. DOI: https://doi.org/10.1186/s12916-016-0718-z
  2. National Institute for Health and Care Excellence. Gastro-oesophageal reflux disease and dyspepsia in adults: investigation and management. NICE guideline CG184. London, UK: NICE; 2022.
  3. Forgacs I, Loganayagam A. Overprescribing proton pump inhibitors. BMJ 2008;336:2-3. DOI: https://doi.org/10.1136/bmj.39406.449456.BE
  4. Farrell B, Pottie K, Thompson W, et al. Deprescribing proton pump inhibitors: evidence-based clinical practice guideline. Can Fam Physician 2017;63:354-64.
  5. Visconti M. Proton pump inhibitors overuse: only inappropriate prescriptions or further iatrogenic damage? Ital J Med 2015;9:217-28. DOI: https://doi.org/10.4081/itjm.2015.562
  6. Bell CM, Brener SS, Gunraj N, et al. Association of ICU or hospital discharge with unintentional continuation of medications intended for acute illness. JAMA 2011;306:2525-33. DOI: https://doi.org/10.1001/jama.2011.1206
  7. Targownik LE, Fisher DA, Saini SD. AGA clinical practice update on de-prescribing of proton pump inhibitors: expert review. Gastroenterology 2022;162:1334-42. DOI: https://doi.org/10.1053/j.gastro.2021.12.247
  8. Wilsdon TD, Hendrix I, Thynne TR, Mangoni AA. Effectiveness of interventions to reduce chronic proton pump inhibitor use: a systematic review. Br J Clin Pharmacol 2017;83:662-75.
  9. Agenzia Italiana del Farmaco. Nota AIFA N01: indicazioni per la prescrivibilità a carico del SSN degli inibitori di pompa protonica. Determina PRES n. 238/2026. Rome, Italy: AIFA; 2026.
  10. Osservatorio Nazionale sull'Impiego dei Medicinali. L'uso dei farmaci in Italia. Rapporto nazionale anno 2024. Rome, Italy: Agenzia Italiana del Farmaco; 2025.
  11. Almegren MO. Assessment and predictors of inappropriate dose of direct oral anticoagulants. Ital J Med 2024;18:1679. DOI: https://doi.org/10.4081/itjm.2024.1679
  12. Maiello M, Proce F, Caputo C, et al. Continuity of care in acute coronary syndrome: why dedicated clinics for post-acute coronary syndrome management make the difference. Ital J Med 2025;19:2054. DOI: https://doi.org/10.4081/itjm.2025.2054

Metrics

Citations and online attention from Dimensions, Altmetric and PlumX.

PlumX Metrics

License

Copyright (c) 2026 the Author(s)

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.